Autolus Therapeutics to Present Four Clinical Data Updates
- AUTO4: oral presentation on initial clinical experience in peripheral T cell lymphoma- AUTO1/22: oral presentation on initial experience in r/r pediatric...
Stay updated with breaking news from Abstract Code. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- AUTO4: oral presentation on initial clinical experience in peripheral T cell lymphoma- AUTO1/22: oral presentation on initial experience in r/r pediatric...
12.05.2022 - Clinical Updates for HM43239 and Luxeptinib Poster Presentation for HM43239 is Scheduled for June 10th at EHA2022 Hybrid Congress SAN DIEGO and TORONTO, May 12, 2022 (GLOBE NEWSWIRE) - Aptose Biosciences Inc. (“Aptose” or the “Company”) ...
Clinical Updates for Luxeptinib in AML & B-cell Cancers and for APTO-253 in AML & MDS Poster Presentations for CG-806 and APTO-253 are Scheduled for June 11th at EHA2021... | May 27, 2021